Company: CORT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001628280-25-019942
Chunk: 33

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 33
---
                                    — |     | $                         |       — |
| William Guyer, Pharm.D.  |     |                                90,000 |     | $                          |  1,409,081 |     |                                2,559 |     | $                         |  87,417 |
| Sean Maduck              |     |                               135,000 |     | $                          |  2,924,789 |     |                                4,156 |     | $                         | 134,816 |
| Atabak Mokari            |     |                                     — |     | $                          |          — |     |                                3,817 |     | $                         | 123,477 |
| Charles Robb             |     |                             47,000(4) |     | $                          |  1,526,880 |     |                                4,829 |     | $                         | 156,031 |

| (1) |     | The value realized on exercise represents, for each share exercised, the excess of the closing trading price of our common stock on the date of exercise over the exercise price of the option.                       |
| (2) |     | The value realized on vesting represents the market price of the underlying shares at vesting and does not necessarily reflect actual proceeds received.                                                              |
| (3) |     | 450,000 shares acquired on exercise by Dr. Belanoff were issued as part of a cashless option exercise whereby 259,583 shares were surrendered to us in satisfaction of the related exercise cost and tax obligations. |
| (4) |     | 14,000 shares acquired on exercise by Mr. Robb were issued as part of a cashless option exercise whereby 8,174 shares were surrendered to us in satisfaction of the related exercise cost and tax obligations.        |

#### Pension Benefits
None of our named executive officers participate in or have account balances in qualified or non-qualified defined benefit plans sponsored by us.

#### Nonqualified Deferred Compensation
None of our named executives participate in or have account balances in non-qualified defined contribution plans or other deferred compensation plans maintained by us.

Potential Payments Upon Termination or Change in Control

Severance and Change in Control Agreements

We have entered into Severance and Change in Control Agreements with each of our named executive officers. The terms of the agreements are identical. They provide that if the executive’s employment is terminated by us without “cause” or by the executive for “